Skip to content
A Green Sign – Lifestyle
Author:
Healome Therapeutics
Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases
July 7, 2026